TAM
DERM icon

Titleist Asset Management’s Journey Medical DERM Stock Holding History

Titleist Asset Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,900
Closed -$99.5K – 399
2025
Q4 		$99.5K Hold
12,900
– – 0.01% 374
2025
Q3 		$91.8K Hold
12,900
– – 0.01% 313
2025
Q2 		$92.6K Hold
12,900
– – 0.01% 315
2025
Q1 		$76.1K Buy
12,900
+2,000
+18% +$9.83K 0.01% 292
2024
Q4 		$42.6K Sell
10,900
-3,350
-24% -$18.3K ﹤0.01% 305
2024
Q3 		$80.5K Buy
+14,250
New +$73.4K 0.01% 274

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Titleist Asset Management's DERM Position: Q1 2026 in Review

Titleist Asset Management sold out of Journey Medical (DERM) in Q1 2026, closing a stake of 12,900 shares — an estimated $99.5K sold.

Titleist Asset Management first reported a position in DERM in Q3 2024 and held it in 6 quarters. The position peaked at $99.5K in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Titleist Asset Management reported no remaining Journey Medical position as of Q1 2026 after selling out during the quarter.
  • Titleist Asset Management sold 12,900 Journey Medical shares in Q1 2026, an estimated $99.5K.
  • Titleist Asset Management first reported a position in Journey Medical in Q3 2024 and held it in 6 quarters.
  • Titleist Asset Management's Journey Medical position peaked at $99.5K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Titleist Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.